C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy

• Elena Panayiotou,

  Affiliation Clinic A, Neuropathology Department, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus

  ⨯
• Eleni Fella,

  Affiliation The Cyprus School of Molecular Medicine, Nicosia, Cyprus

  ⨯
• Revekka Papacharalambous,

  Affiliation Clinic A, Neuropathology Department, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus

  ⨯
• Stavros Malas,

  Affiliation Clinic A, Neuropathology Department, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus

  ⨯
• Maria Joao Saraiva,

  Affiliation Instituto de Inovação e Investigação em Saúde (I3S) and Neurobiologia Molecular-Instituto de Biologia Molecular (IBMC) - Universidade do Porto, Porto, Portugal

  ⨯
• Theodoros Kyriakides

  * E-mail: theodore@cing.ac.cy

  Affiliations Clinic A, Neuropathology Department, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus, The Cyprus School of Molecular Medicine, Nicosia, Cyprus

  http://orcid.org/0000-0002-0017-7143

  ⨯